Janssen Pharmaceuticals, Inc.

FDA inspection history in Athens, Georgia, 2025

1
Form 483

Every document, by year

  • Form 483

2025: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2025One Form 483, at Athens, Georgia.

Cited most

Across all Janssen Pharmaceuticals observations on file

  • 21 CFR 211.84
    Testing and approval or rejection of components, drug product containers, and closures
    1

The complete Janssen Pharmaceuticals file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2025-01-24483 Form 483$99

Investigators on these documents

Kara J. Wright (1)

FEI number 1033845 · most recent document Jan 24, 2025

About Janssen Pharmaceuticals, Inc.

How many FDA Form 483s has Janssen Pharmaceuticals, Inc. received?

FDA Intel has 1 Form 483 on file for Janssen Pharmaceuticals, Inc.; the most recent is dated Jan 24, 2025.

When was Janssen Pharmaceuticals, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Janssen Pharmaceuticals, Inc. is a Form 483 dated Jan 24, 2025, for the site in Athens, Georgia.

What did FDA cite at Janssen Pharmaceuticals, Inc.?

The regulations cited most in the observations on file for Janssen Pharmaceuticals, Inc. are 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time.